OncLive.com (@onclive) 's Twitter Profile
OncLive.com

@onclive

Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.

ID: 43051682

linkhttp://www.onclive.com calendar_today28-05-2009 05:04:27

104,104K Tweet

45,45K Followers

1,1K Following

OncLive.com (@onclive) 's Twitter Profile Photo
OncLive.com
@onclive

14 days ago

The EC approved erdafitinib monotherapy for the treatment of adult patients with unresectable or mUC harboring susceptible FGFR3 genetic alterations who have previously received at least 1 prior line of therapy containing a PD-(L)1 inhibitor. #oncology onclive.com/view/erdafitin…

The EC approved erdafitinib monotherapy for the treatment of adult patients with unresectable or mUC harboring susceptible FGFR3 genetic alterations who have previously received at least 1 prior line of therapy containing a PD-(L)1 inhibitor. #oncology onclive.com/view/erdafitin…